ASX-Dividend-Report-Banner

Healthcare


 Syntara (ASX:SNT) shareholders have experienced remarkable returns, over the past year.

Syntara (ASX:SNT) shareholders have experienced remarkable returns,...

March 19, 2025 09:33 AM AEDT | By Team Kalkine Media

Highlights,SNT shares soared by an impressive 305% over the past year.,Recent financial results indicate significant revenue growth.,Long-term shareho...

 Pro Medicus Limited (ASX:PME) have recently been purchasing more shares.

Pro Medicus Limited (ASX:PME) have recently been purchasing more sha...

March 19, 2025 09:32 AM AEDT | By Team Kalkine Media

Highlights,Insiders hold 49% of ASX:PME shares, indicating significant vested interests.,Top 4 shareholders control 51% of the company, influencing ke...

 Orthocell (ASX:OCC) Expands Global Footprint with Singapore Approval for Striate+

Orthocell (ASX:OCC) Expands Global Footprint with Singapore Approval...

March 18, 2025 05:08 PM AEDT | By Team Kalkine Media

Highlights,Singapore’s Health Sciences Authority grants approval for Striate+,Global sales growth continues with strong adoption rates,Expansion effor...

 CLEO Diagnostics initiates the transfer of intellectual property for ovarian cancer blood tests to manufacturers in the US.

CLEO Diagnostics initiates the transfer of intellectual property for...

March 18, 2025 03:31 PM AEDT | By Team Kalkine Media

Highlights:,CLEO Diagnostics progresses with technology transfer for its ovarian cancer blood test.,Collaboration with R&D Systems Inc supports antibo...

 Invex Therapeutics (ASX:IXC) - A Glimpse of Change

Invex Therapeutics (ASX:IXC) - A Glimpse of Change

March 18, 2025 03:30 PM AEDT | By Team Kalkine Media

Highlights,Invex Therapeutics shares increased by 12% in a week,A significant decrease of 88% over three years,Total Shareholder Return (TSR) outperfo...

 Would Next Science (NXS) Benefit from Reducing Its Debt?

Would Next Science (NXS) Benefit from Reducing Its Debt?

March 18, 2025 03:30 PM AEDT | By Team Kalkine Media

Highlights:,Next Science reports a low net debt position with liquid assets nearly balancing liabilities.,The company’s revenue has grown, though oper...

 Chimeric Therapeutics (ASX:CHM) Launches $3.2M Entitlement Offer to Advance Cancer Trials

Chimeric Therapeutics (ASX:CHM) Launches $3.2M Entitlement Offer to...

March 18, 2025 02:01 PM AEDT | By Team Kalkine Media

Highlights,Chimeric Therapeutics (CHM) announces a $3.2 million entitlement offer.,Funds to support ongoing clinical trials in neuroendocrine, colorec...

 Major Developments in ASX Health and Biotech Firms

Major Developments in ASX Health and Biotech Firms

March 18, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights,Nanosonics receives FDA clearance for Coris, aimed at improving infection control in hospitals.,Imricor secures substantial funding for acc...

 Medical Developments International (ASX:MVP) Sees Sharp Drop – What’s Behind It?

Medical Developments International (ASX:MVP) Sees Sharp Drop – What’...

March 17, 2025 06:56 PM AEDT | By Team Kalkine Media

Highlights,Medical Developments International (MVP) has declined by 27% in the last month.,The stock's price-to-sales ratio is significantly lower tha...

 Global Health (ASX:GLH) Expands Digital Healthcare with $1 Million Youturn Partnership

Global Health (ASX:GLH) Expands Digital Healthcare with $1 Million Y...

March 17, 2025 05:12 PM AEDT | By Team Kalkine Media

Highlights,Global Health (GLH) secures a $1 million contract with Youturn for digital health solutions.,The partnership aims to streamline operations...

 Is Ansell Limited (ASX:ANN) Facing Market Pressure Due to Financial Performance?

Is Ansell Limited (ASX:ANN) Facing Market Pressure Due to Financial...

March 17, 2025 02:01 PM AEDT | By Team Kalkine Media

Highlights,Ansell Limited (ANN) has seen a 7.2% decline in stock value over the past month.,The company's return on equity (ROE) stands at 5.9%, below...

 Ebos Group Dismisses Speculation on Real Pet Food Company Acquisition

Ebos Group Dismisses Speculation on Real Pet Food Company Acquisitio...

March 17, 2025 12:55 PM AEDT | By Team Kalkine Media

Highlights,Ebos,Group (,ASX:EBO,) refutes reports of pursuing Real Pet Food Company.,Company,maintains,its focus on strategic, small-to-medium acquisi...

 EMVision prepares for crucial stroke scanner trial this year

EMVision prepares for crucial stroke scanner trial this year

March 17, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights:,EMVision progresses from development to commercialization with portable brain scanners for stroke diagnosis.,A pivotal clinical trial supp...

 US FDA Approvals: A Crucial Step for ASX Biotech Companies

US FDA Approvals: A Crucial Step for ASX Biotech Companies

March 17, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlight,FDA approval remains pivotal for global drug and device companies seeking market entry into the profitable US healthcare market.,ASX biotech...

 Neurizon Therapeutics Advances Pharmacokinetic Studies to Address FDA Hold

Neurizon Therapeutics Advances Pharmacokinetic Studies to Address FD...

March 17, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlight,Neurizon submits a request to the FDA for clarification on pharmacokinetic studies to lift the clinical hold on NUZ-001.,The FDA is expected...

 Race initiates its first Phase I trial location for a cardioprotective anticancer drug candidate.

Race initiates its first Phase I trial location for a cardioprotecti...

March 16, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights,Race Oncology commences Phase I trials of RC220 in New South Wales, marking progress in its oncology treatment strategy.,The study evaluate...

 Race receives ethical approval for Phase I trial in patients with solid tumors.

Race receives ethical approval for Phase I trial in patients with so...

March 14, 2025 11:00 AM AEDT | By Team Kalkine Media

Highlights:,Ethics approval secured for a Phase I trial of RC220 bisantrene targeting solid tumors.,Patient enrollment set to begin at Southside Cance...

 Oakridge International Insider Trust Pays Off as Stock Reaches AU$1.9 Million Market Cap

Oakridge International Insider Trust Pays Off as Stock Reaches AU$1....

March 13, 2025 05:31 PM AEDT | By Team Kalkine Media

Highlights,Recent share surge leads to significant gains for insiders.,Executive Chairman & CEO's substantial share purchase stands out.,Strong inside...

 We're Eager to See How Mach7 Technologies Utilizes Its Cash Reserve for Growth

We're Eager to See How Mach7 Technologies Utilizes Its Cash Reserve...

March 13, 2025 05:30 PM AEDT | By Team Kalkine Media

Highlights:,Mach7 Technologies maintains a strong financial position with a substantial cash reserve and no debt.,Revenue growth has been steady, demo...

 Early Detection of Diabetic Kidney Disease Gets a Boost with PromarkerD Launch in Australia

Early Detection of Diabetic Kidney Disease Gets a Boost with Promark...

March 13, 2025 02:14 PM AEDT | By Team Kalkine Media

Highlights,PromarkerD,launched in Australia for early diabetic kidney disease detection,Study shows,PromarkerD,outperforms standard tests in predictin...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.